Cell MedX Corp. is an early development-stage company publicly traded on the OTC Markets under the symbol CMXC. The Company is focused on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes by developing technologies to aid in the management of the illness and related complications.
Right now there are 382 million people living with diabetes worldwide. This number is likely to grow to almost 500 million within a generation.
Chances are, this means you, or someone you know, needs help today.